1. Home
  2. LAC vs STTK Comparison

LAC vs STTK Comparison

Compare LAC & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lithium Americas Corp.

LAC

Lithium Americas Corp.

N/A

Current Price

$1.67

Market Cap

686.2M

ML Signal

N/A

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

N/A

Current Price

$5.07

Market Cap

652.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LAC
STTK
Founded
2023
2016
Country
Canada
United States
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
686.2M
652.4M
IPO Year
2023
2020

Fundamental Metrics

Financial Performance
Metric
LAC
STTK
Price
$1.67
$5.07
Analyst Decision
Hold
Strong Buy
Analyst Count
12
12
Target Price
$5.07
★ $15.40
AVG Volume (30 Days)
★ 7.5M
931.7K
Earning Date
11-13-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 53.02
EPS
★ N/A
N/A
Revenue
N/A
★ $1,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$14.28
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.78
$1.72
52 Week High
$6.96
$8.33

Technical Indicators

Market Signals
Indicator
LAC
STTK
Relative Strength Index (RSI) 29.45 40.68
Support Level N/A $3.55
Resistance Level $2.22 $5.98
Average True Range (ATR) 0.13 0.39
MACD 0.00 -0.04
Stochastic Oscillator 1.85 35.03

Price Performance

Historical Comparison
LAC
STTK

About LAC Lithium Americas Corp.

Lithium Americas Corp is a Canadian-based resource and materials company focused on developing, building and operating lithium deposits and chemical processing facilities. The company also holds investments in Green Technology Metals Limited (GT1) and Ascend Elements, Inc. (Ascend Elements), and exploration properties in the U.S. and Canada. The company's flagship asset is Thacker Pass, a sedimentary-based lithium deposit located in the McDermitt Caldera in Humboldt County, in northern Nevada (Thacker Pass or the Project). The company operates in only one operating segment and one geographical segment.

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

Share on Social Networks: